Precision Medicine in Oncology: Ep.5 Precision medicine for metastatic colorectal cancer

IMPACT Medicom

Contenu fourni par IMPACT Medicom. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par IMPACT Medicom ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

3+ y ago 22:22

MP3•Maison d'episode

In this episode of IMPACT Medicom’s podcast series on Precision Medicine in Oncology we discuss:

· The current standards for molecular testing in metastatic colorectal cancer

· The potential benefit of a Canadian guideline for molecular testing in metastatic colorectal cancer

Our guest:

Dr. Sharlene Gill is Professor of Medicine at the University of British Columbia and Medical Oncologist at BC Cancer in Vancouver. Dr. Gill earned her MD from the University of British Columbia and completed a fellowship in gastrointestinal oncology at the Mayo Clinic (Rochester, MN). She also received a Master of Public Health degree from the Harvard School of Public Health and completed her MBA at the Kenan-Flagler School of Business at the University of North Carolina. Dr. Gill currently specializes in the treatment of gastrointestinal malignancies and serves as the Chair of the Canadian Clinical Trials Group GI Disease Site Committee. In addition, she is President-Elect of the Canadian Association of Medical Oncologists and is Editor-in-Chief for the peer-reviewed journal Current Oncology.

This podcast episode was sponsored by Merck Canada.

If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com

67 episodes

#Science #Medical Communications #Medical Writing #Agency